絞り込み

16501

広告

[Antibodies as treatment option in older adults].

著者 Gosch M , Wicklein S
Z Gerontol Geriatr.2017 Dec 20 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (32view , 0users)

Full Text Sources

Monoclonal antibodies are already used for many different clinical indications. Besides oncology and rheumatology, denosumab is the only antibody that is currently prescribed in older adults with osteoporosis; however, apart from osteoporosis there might be more possible indications for the use of antibodies in chronic diseases and geriatric syndromes. Particularly, with respect to sarcopenia the transition to "doping for older adults" seems to be fluent. The present review provides an overview on the newest developments and prospective options.
PMID: 29264687 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード